COMPARISON OF CLINICAL, BIOLOGICAL AND EVOLUTIONARY CHARACTERISTICS BETWEEN CHILDHOOD ACUTE LYMPHOBLASTIC AND MYELOID LEUKEMIA IN WESTERN ALGERIA, FROM 2016 TO 2018
Abstract
Background and Objectives: Haematological malignancies account for approximately 40% of all cancers by the age of 15 years. Acute leukaemia (AL) account for one-third of childhood cancer cases; consisting of Acute Lymphoblastic Leukaemia (ALL) and Acute Myeloid Leukaemia (AML). The aim of this work is to describe the epidemiological, clinical, biological and evolutionary characteristics of children with acute leukaemia in the western and south-western region of Algeria.
Patients and Methods: A three-year retrospective study was undergone from January 2016 to December 2018 on children with acute leukaemia. The study was conducted at the paediatric oncology department of the anti-cancer -Emir AEK- of Missreghine in Oran.
Results: During this period, we identified 135 cases of diagnosed AL. The sex ratio M/F was 1.1. The “two to five-year” age group was the most affected. The prevalence of ALL, AML, and biphenotypic acute leukaemia (BAL) was 60.45%, 23.88%, and 15.57%, respectively. The clinical signs were mainly presented by the tumour syndrome dominated by the presence of lymphadenopathy (63%) and splenomegaly (56.3%). The most frequent abnormal blood abnormalities were anaemia (66.66% in ALL and 28.14% in AML), thrombocytopenia (75.9% in ALL and 24.4% in AML) and leukocytosis (76.3% ALL and 23.7% AML).
Conclusion: Paediatric acute leukaemia is a real public health problem that requires special care and attention. This management must involve all epidemiological, clinical and biological aspects for this highly sensitive age group.
Keywords:
Childhood cancer, Acute Lymphoblastic Leukaemia, Acute Myeloid LeukaemiaDOI
https://doi.org/10.22270/jddt.v10i4.4202References
Guyot-Goubin A, Clavel J. Les hémopathies malignes. In: Épidémiologie des cancers de l’enfant, eds. Springer, Paris, 2009: 49-54.
Pommert L, Margossian S, Burke M, “Diagnosis and Treatment-Related Complications of Acute Leukemia. In: Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient, eds. Springer, Boston, 2019: 9-27.
Braham-Jmili N, Sendi-Senana H, Khelif A, Saad A, “Leucémies aiguës myéloïdes en Tunisie : caractéristiques épidémiologiques et cliniques et classification OMS“ J Afr Cancer, 2010 ; 2:25-32. https://doi.org/10.1007/s12558-010-0062-8.
Harioly Nirina MOM, Rakotoarivelo ZL, Ntoezara A, Rasolonjatovo AS, RakotoAlson AO, Rasamindrakotroka A, “Épidémiologie et diagnostic des leucémies aiguës à l’hôpital Ravoahangy Andrianavalona Antananarivo Madagascar" J Afr Cancer, 2015 ; 7:186-189. https://doi.org/10.1007/s12558-015-0393-6.
Donadieu J, Auclerc MF, Baruchel A, Leblanc T, Landman‐Parker J, Perel Y, Michel G, Cornu G, Bordigoni P, Sommelet D, Leverger G, Hill C, Schaison G, "Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables" British Journal of Haematology, 1998; 102 (3):729-739. https://doi.org/10.1046/j.1365-2141.1998.00818.x.
Petrov I, Suntsova M, Mutorova O, Sorokin M, Garazha A, Ilnitskaya E, Spirin P, Larin S, Kovalchuk O, Prassolov V, Zhavoronkov A, Roumiantsev A, Buzdin A, "Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells" Aging (Albany NY), 2016; 8(11):2936-2947. doi: 10.18632/aging.101102.
Sabbah L. Leucémies aiguës. In: Mega guide stages IFSI, eds. Elsevier Masson. 2nd ed. Paris, 2015: 121-125.
Belson M, Kingsley B, Holmes A, "Risk factors for acute leukemia in children: a review", Environ Health Perspect, 2007;115(1):138-145.
Abdul Hamid G. Acute Leukemia Clinical Presentation. In: LEUKEMIA, eds. InTech. Croatia, 2013: 75-97.
Doumbia M, Uwingabiye J, Bissan A, Rachid R, Benkirane S, Masrar A, "Aspects épidémiologiques, cliniques, cytologiques et immunophénotypiques des leucémies aiguës chez les enfants : expérience du laboratoire d’hématologie du Centre Hospitalier Universitaire IBN Sina" Pan Afr Med J, 2016; 23:258.
Preudhome C, "Biologie moléculaire et leucémies aiguës" Revue Française des Laboratoires, 2002 ; 2002(344):41-46.
Coebergh JW, Reedijk AM, de Vries E, Martos C, Jakab Z, Steliarova-Foucher E, Kamps WA, "Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project" Eur J Cancer, 2006 42(13):2019-2036.
Dargahi T, Goudarzi M, MobarraN, Poorkarim H, Rahmani S, Khalili M, Amini M, Hamedani J, Azad M, "Investigation of Leukemia Frequency in Children of Qazvin Province and its Correlation with Gender, Age, and Blood Groups between 2006-2016" Novel Biomed, 2016; 4(4):135-141. https://doi.org/10.22037/nbm.v4i4.14670.
Cumin I, Mechinaud-Lacroix F, Avet-Loiseau H, Fischer A, Harousseau JL, "Leucémies aiguës néonatales: à propos de sept observations" Archives de Pédiatrie, 1995; 2(11): 1060-1066. https://doi.org/10.1016/0929-693X(96)81281-4.
Kaldor JM, Day NE, Clarke EA, Van Leeuwen FE, Henry-Amar M, Fiorentino MV, et al. Leukemia following Hodgkin's disease. N Engl J Med, 1990; 322(1):7-13. doi: 10.1056/NEJM199001043220102.
Lanzkowsky P. Leukemias. In: Manual of Pediatric Hematology and Oncology, eds. Elsevier. 4th ed. London, 2005:415-452.
Perel Y. Cancers et leucémies de l’enfant et de l’adolescent. In: Pédiatrie, eds. Elsevier Masson. 6th ed. Paris, 2011: 419-426.
Barrington-Trimis JL, Cockburn M, Metayer C, Gauderman WJ, Wiemels J, McKean-Cowdin R, "Trends in childhood leukemia incidence over two decades from 1992 to 2013" Int J Cancer, 2017; 140(5): 1000-1008. doi: 10.1002/ijc.30487.
Roganovic J. Acute Leukemia Clinical Presentation. In: LEUKEMIA, eds. InTech. Croatia, 2013: 39-74.
Esparza SD, Sakamoto KM, “Topics in pediatric leukemia--acute lymphoblastic leukemia” Med Gen Med, 2005; 7(1):23.
Jaime-Pérez JC, García-Arellano G, Herrera-Garza JL, Marfil-Rivera LJ, Gómez-Almaguer D, “Revisiting the complete blood count and clinical findings at diagnosis of childhood acute lymphoblastic leukemia: 10-year experience at a single center” Hematol Transfus Cell Ther, 2019; 41(1): 57-61. DOI: 10.1016/j.htct.2018.05.010.
Sall A, Sène A, Djiba B, Diallo M, Faye BF, Seck M, Gadji M, Dièye TND, Touré AO, Diop S, Raphaël M, “Leucémie prolymphocytaire T: à propos d’une observation et revue de la littérature" J Afr Cancer, 2015 ; 7:236-239. https://doi.org/10.1007/s12558-015-0388-3.
Acharya S, Maiti D, Datta S, “Clinico-epidemiological study of extramedullary disease manifestations in childhood acute lymphoblastic leukaemia in a tertiary care centre” Int J Contemp Pediatr, 2018; 5(4):1637-1640. DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20182580.
Flatrès C, Pennanéach A, Blondin G, Rivoal E, Haro S, Vic P, "Leucémie aiguë découverte par imagerie par résonance magnétique osseuse : deux observations pédiatriques" Archives de Pédiatrie, 2017; 24(6):542-546. https://doi.org/10.1016/j.arcped.2017.03.015.
Béné MC, Lacombe F, "Place de la cytométrie en flux dans le diagnostic et le suivi des leucémies aiguës" Revue Francophone des Laboratoires, 2015; 2015(471):35-41.
Mwirigi A, Dillon R, Raj K, "Acute leukaemia" Medicine, 2017; 45(5):280-286.
Lahlou Z, Lafhel I, Maani K, Hachim J, Itri A, "Leucémies aigues de l’enfant : Etude de 142 cas" Archives de Pédiatrie, 2014; 21(5)supp1:357. https://doi.org/10.1016/S0929-693X(14)71617-3.
Published
Abstract Display: 658 
PDF Downloads: 845 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.